Status:
COMPLETED
Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Coronary Disease
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Single nucleotide polymorphisms at codon 46 and 79 of the gene encoding for the ß2 adrenergic receptor (ß2AR) modify its pharmacological properties and may alter the response to ß2AR agonists. The goa...
Eligibility Criteria
Inclusion
- patients scheduled to undergo coronary artery bypass graft operation
Exclusion
- Chronic treatment with corticosteroids
Key Trial Info
Start Date :
August 1 1999
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00226551
Start Date
August 1 1999
Last Update
October 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel